MX362885B - Pastilla para tratar garganta irritada, ronquera y tos seca asociada, y enfermedades inflamatorias de la cavidad oral y faringea. - Google Patents

Pastilla para tratar garganta irritada, ronquera y tos seca asociada, y enfermedades inflamatorias de la cavidad oral y faringea.

Info

Publication number
MX362885B
MX362885B MX2015013934A MX2015013934A MX362885B MX 362885 B MX362885 B MX 362885B MX 2015013934 A MX2015013934 A MX 2015013934A MX 2015013934 A MX2015013934 A MX 2015013934A MX 362885 B MX362885 B MX 362885B
Authority
MX
Mexico
Prior art keywords
treating
inflammatory diseases
hoarseness
pharynx
lozenge
Prior art date
Application number
MX2015013934A
Other languages
English (en)
Other versions
MX2015013934A (es
Inventor
Plohmann Bernd
Boni Julia
Sauerland Sandra
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47997281&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX362885(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of MX2015013934A publication Critical patent/MX2015013934A/es
Publication of MX362885B publication Critical patent/MX362885B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/577—Malvaceae (Mallow family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/10—Bryophyta (mosses)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/68—Plantaginaceae (Plantain Family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La presente invención se relaciona con una formulación farmacéutica que contiene una combinación de (a) al menos una sustancia activa astringente y (b) al menos un fármaco mucilaginoso y el uso de eso de los mismos para la prevención o tratamiento de enfermedades inflamatorias de la región orofaringea y/o para el tratamiento de irritaciones dolorosas de la mucosa en la región orofaríngea y la tos irritable asociada.
MX2015013934A 2013-04-02 2014-03-31 Pastilla para tratar garganta irritada, ronquera y tos seca asociada, y enfermedades inflamatorias de la cavidad oral y faringea. MX362885B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13161902 2013-04-02
PCT/EP2014/056437 WO2014161811A1 (de) 2013-04-02 2014-03-31 Lutschtablette zur behandlung von halsschmerz, heiserkeit und assoziiertem trockenen husten, sowie entzündlichen erkrankungen des mund und rachenraums

Publications (2)

Publication Number Publication Date
MX2015013934A MX2015013934A (es) 2015-12-08
MX362885B true MX362885B (es) 2019-02-22

Family

ID=47997281

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015013934A MX362885B (es) 2013-04-02 2014-03-31 Pastilla para tratar garganta irritada, ronquera y tos seca asociada, y enfermedades inflamatorias de la cavidad oral y faringea.

Country Status (13)

Country Link
US (2) US20140294995A1 (es)
EP (1) EP2981275B1 (es)
JP (1) JP6491191B2 (es)
KR (1) KR102218148B1 (es)
CN (1) CN105050610A (es)
AU (1) AU2014247141B2 (es)
BR (1) BR112015020019B1 (es)
CA (1) CA2906272A1 (es)
EA (1) EA030913B1 (es)
ES (1) ES2717663T3 (es)
MX (1) MX362885B (es)
PH (1) PH12015502274B1 (es)
WO (1) WO2014161811A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104823249B (zh) 2013-05-31 2018-01-05 北京有色金属研究总院 稀土永磁粉、包括其的粘结磁体及应用该粘结磁体的器件
IT201700016964A1 (it) * 2017-02-15 2018-08-15 Aboca Spa Societa Agricola Composizione per la tosse
EP3459368B1 (en) * 2017-09-20 2025-08-20 Geophyt S.r.L. Food integrator for antineoplastic therapies
EP4059508A1 (en) * 2021-03-19 2022-09-21 Johnson & Johnson Consumer Inc. Methods of using compositions comprising an iceland moss extract
FR3144752A1 (fr) 2023-01-10 2024-07-12 Song Huang Utilisation de polysulfate de pentosane pour le traitement de la toux seche

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3042917B2 (ja) * 1991-09-12 2000-05-22 日本化薬株式会社 ペースト及びペースト製剤
CN1283296C (zh) * 2004-04-29 2006-11-08 吕文晓 一种咽喉保健茶及其制备方法
WO2007089652A2 (en) * 2006-01-27 2007-08-09 Cadbury Adams Usa Llc Flavor-enhancing compositions, methods of manufacture, and methods of use
DE202006009570U1 (de) * 2006-06-16 2007-07-26 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Reizlinderndes Hustenmittel
JP5578646B2 (ja) * 2009-06-19 2014-08-27 株式会社和漢生薬研究所 咽頭炎用及びインフルエンザ予防・治療用の経口投与組成物
JP5673560B2 (ja) * 2010-01-29 2015-02-18 パナセア ディシンフェクタント カンパニー リミテッド 持続性口腔用殺菌消毒液
EP2361623A1 (en) * 2010-02-09 2011-08-31 Novintethical Pharma, SAGL Composition comprising a polyphenol salt and corresponding use

Also Published As

Publication number Publication date
US20140294995A1 (en) 2014-10-02
ES2717663T3 (es) 2019-06-24
PH12015502274A1 (en) 2016-02-01
CA2906272A1 (en) 2014-10-09
PH12015502274B1 (en) 2021-09-08
AU2014247141A1 (en) 2015-09-10
JP6491191B2 (ja) 2019-03-27
KR20150136540A (ko) 2015-12-07
US20160193267A1 (en) 2016-07-07
BR112015020019B1 (pt) 2021-05-18
KR102218148B1 (ko) 2021-02-23
BR112015020019A2 (pt) 2017-07-18
EP2981275A1 (de) 2016-02-10
CN105050610A (zh) 2015-11-11
AU2014247141B2 (en) 2018-07-05
WO2014161811A1 (de) 2014-10-09
EP2981275B1 (de) 2019-01-09
US10004774B2 (en) 2018-06-26
JP2016515594A (ja) 2016-05-30
MX2015013934A (es) 2015-12-08
EA201500992A1 (ru) 2016-03-31
EA030913B1 (ru) 2018-10-31

Similar Documents

Publication Publication Date Title
MX2019001481A (es) Derivado de oxopicolinamida, metodo de preparacion y uso farmaceutico del mismo.
BR112015022197A8 (pt) uso de um composto para fabricação de um medicamento ou composição farmacêutica para o tratamento de cataplexia
MX2015010139A (es) Composicion antiseptica oral para tratamiento de mucositis oral.
PE20142319A1 (es) Tratamiento de esclerosis multiple con combinacion de laquinimod y acetato de glatiramero
CL2017003066A1 (es) Composiciones de carbonato de calcio amorfo para administración mediante inhalación, sublingual o bucal
CL2016002560A1 (es) Forma de dosificación farmacéutica sólida oral que comprende siponimod, un agente protector de la humedad y opcionalmente un excipiente farmacéutico; procedimiento de preparación.
AR096892A1 (es) Una combinación farmacéutica para el tratamiento del melanoma
MX362885B (es) Pastilla para tratar garganta irritada, ronquera y tos seca asociada, y enfermedades inflamatorias de la cavidad oral y faringea.
CL2017001913A1 (es) Composición tópica curativa
CL2019002218A1 (es) Formulaciones de combinación triple y métodos para tratar o reducir el riesgo de enfermedad cardiovascular.
MX2017004772A (es) Composiciones y métodos para la administración fisiológica utilizando cannabidiol.
BR112018015367A2 (pt) carreadores oromucosais de nanofibra para tratamento terapêutico
MX2015012315A (es) Uso de levocetirizina y montelukast en el tratamiento de lesion traumatica.
AR102778A1 (es) Composición farmacéutica, su preparación y sus usos
MX2015013115A (es) Nuevos regimenes de dosificacion de celgosivir para el tratamiento de dengue.
UY35890A (es) Uso de laquinimod para retrasar la progresión de la enfermedad de huntington
MX2016011025A (es) Composiciones de grapiprant y metodos para usar las mismas.
CO2018002428A2 (es) Amida seleccionada de ácido gamma-hidroxiburico y usos de la misma en el tratamiento de abuso de alcohol
UY31826A (es) Compuesto peptídico y su uso
CL2019003288A1 (es) Una combinación farmacéutica para el tratamiento de un cáncer.
ECSP16005208A (es) Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido recubierto que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación
BR112015023368A2 (pt) método de tratamento de deficiência de vitamina b12
MX2015009681A (es) Un medicamento combinado que comprende finilefrina y paracetamol.
CL2022002170A1 (es) Composiciones de palmitato de vitamina a, procesos para su preparación, usos y métodos
ES2422563A1 (es) Composición farmacéutica inyectable de ibuprofeno y arginina, su procedimiento de preparación, forma de dosificación unitaria y utilización de la misma

Legal Events

Date Code Title Description
FG Grant or registration